Mason Capital Management’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q2
Sell
-4,000
Closed -$302K 33
2021
Q1
$302K Buy
+4,000
New +$302K 0.07% 20